Allen G. Li
Phasex (United States)(US)
Publications by Year
Research Areas
TGF-β signaling in diseases, Hedgehog Signaling Pathway Studies, Wnt/β-catenin signaling in development and cancer, Hair Growth and Disorders, Cancer-related gene regulation
Most-Cited Works
- → Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974(2013)825 cited
- → Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors(2010)596 cited
- → Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials(2013)408 cited
- → Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation(2005)234 cited
- → Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis‐like skin disorder(2004)221 cited
- → Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma(2006)201 cited
- → Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation(2004)195 cited
- → Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development(2006)163 cited
- → Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2(2007)146 cited
- → Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency(2018)138 cited